Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Sramek

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Clinical Pharmacokinetics|March 1, 1992
Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonismN R Cutler, S A Reines, L F McLean, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1994
An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD)N R Cutler, J J Sramek, A E Macpherson, et al.
Journal of Clinical Psychopharmacology|December 1, 1993
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trialN R Cutler, J J Sramek, J M Keppel Hesselink, et al.
Journal of Clinical Psychopharmacology|October 8, 1997
Two rapid-dose titrations of sertindole in patients with schizophreniaJ J Sramek, R J Mack, W Awni, et al.
DICP : the Annals of Pharmacotherapy|December 1, 1989
Effects of carbamazepine on serum calcium in schizophreniaT Tran-Johnson, J J Sramek, N R Walker, et al.
Alzheimer Disease and Associated Disorders|January 1, 1993
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer diseaseA Sudilovsky, N R Cutler, J J Sramek, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.
Journal of Clinical Pharmacology|October 5, 2001
Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's diseaseJ V Gobburu, V Tammara, L Lesko, et al.
Headache|March 20, 1998
Monitoring of acute migraine attacks: placebo response and safety dataS S Jhee, D E Salazar, N F Ford, et al.
The American Journal of Psychiatry|August 1, 1985
Hair analysis for detection of phencyclidine in newly admitted psychiatric patientsJ J Sramek, W A Baumgartner, J A Tallos, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Clinical Pharmacokinetics|March 1, 1992
Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonismN R Cutler, S A Reines, L F McLean, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 1994
An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD)N R Cutler, J J Sramek, A E Macpherson, et al.
Journal of Clinical Psychopharmacology|December 1, 1993
A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trialN R Cutler, J J Sramek, J M Keppel Hesselink, et al.
Journal of Clinical Psychopharmacology|October 8, 1997
Two rapid-dose titrations of sertindole in patients with schizophreniaJ J Sramek, R J Mack, W Awni, et al.
DICP : the Annals of Pharmacotherapy|December 1, 1989
Effects of carbamazepine on serum calcium in schizophreniaT Tran-Johnson, J J Sramek, N R Walker, et al.
Alzheimer Disease and Associated Disorders|January 1, 1993
A pilot clinical trial of the angiotensin-converting enzyme inhibitor ceranapril in Alzheimer diseaseA Sudilovsky, N R Cutler, J J Sramek, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|October 1, 1996
Assessing the neuropsychological profile of stable schizophrenic outpatientsN R Cutler, A E Veroff, E J Frackiewicz, et al.
Journal of Clinical Pharmacology|October 5, 2001
Pharmacokinetic-pharmacodynamic modeling of rivastigmine, a cholinesterase inhibitor, in patients with Alzheimer's diseaseJ V Gobburu, V Tammara, L Lesko, et al.
Headache|March 20, 1998
Monitoring of acute migraine attacks: placebo response and safety dataS S Jhee, D E Salazar, N F Ford, et al.
The American Journal of Psychiatry|August 1, 1985
Hair analysis for detection of phencyclidine in newly admitted psychiatric patientsJ J Sramek, W A Baumgartner, J A Tallos, et al.
Pageof 11